Treatment strategies for Behçet's disease

Expert Opin Pharmacother. 2008 Dec;9(18):3211-9. doi: 10.1517/14656560802457749.

Abstract

Background: Behçet's disease (BD) is a multisytemic vasculitis characterized by oral and genital ulceration, other skin lesions, uveitis and manifestations affecting the blood vessels, CNS and gastrointestinal system. It is rare in the Western world but is frequent in the Middle and Far East.

Objective: The aim of this review is to discuss treatment strategies in BD. These might vary between simple reassurance and a combination of immunosuppressives.

Methods: A systematic literature search was done using the Cochrane and Medline databases in June 2008. The EULAR recommendations for the management of BD were also taken into account.

Conclusion: The last two decades have witnessed considerable improvement in eye disease and musculoskeletal involvement. However, the treatment of thrombophlebitis, CNS, and gastrointestinal manifestations remains problematic.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Drug Therapy, Combination
  • Eye Diseases / drug therapy
  • Eye Diseases / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Musculoskeletal Diseases / drug therapy
  • Musculoskeletal Diseases / etiology
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Thrombophlebitis / drug therapy
  • Thrombophlebitis / etiology

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents